Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)

Name: Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)
License: Public Domain

Novavax

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

influenza

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127664
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.